These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 11572178)
41. Cutting it close. It's the right dose and the right drug--how can it be too much? Karch AM; Karch FE Am J Nurs; 2000 Jan; 100(1):23. PubMed ID: 10705835 [No Abstract] [Full Text] [Related]
43. AstraZeneca reprimanded for nolvadex advertisement. Fintor L J Natl Cancer Inst; 2002 Mar; 94(5):330. PubMed ID: 11880471 [No Abstract] [Full Text] [Related]
44. Evidence based advertising? Half of drug advertisements in BMJ over six months cited no supporting evidence. Smart S; Williams C BMJ; 1997 Dec; 315(7122):1622-3. PubMed ID: 9437302 [No Abstract] [Full Text] [Related]
45. The role of the critical event committee in a major cardiovascular outcome study. Heagerty A; Deverly A; Palmer C; Kaplinsky E; Salvetti A; Wahlgren NG; Funck-Brentano C Blood Press; 2002; 11(6):339-44. PubMed ID: 12523676 [TBL] [Abstract][Full Text] [Related]
46. Users' guide to detecting misleading claims in research: misleading claims may be symptom of even more serious flaws. Penston J BMJ; 2005 Jan; 330(7483):145; author reply 146. PubMed ID: 15649934 [No Abstract] [Full Text] [Related]